Fallbericht
Adalimumab for treatment of severe ulcerative sarcoidosis
Dermatology Online Journal · 15.07.2021 · 27 (6)
DOI: 10.5070/d327654058 ↗Kurz gefasst
Fallbericht in der Zeitschrift Dermatology Online Journal, online erschienen am 15.07.2021. Verfasst von Develyn Vetos und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Dermatology, University of Kansas Medical Center, Kansas City, KS. arajpara@kumc.edu. Die Arbeit wurde bisher 5-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
AdalimumabFemaleHumansMiddle AgedSarcoidosisSeverity of Illness IndexSkin DiseasesSkin Ulcer
Substanzen
Adalimumab
Autor:innen und Institutionen
- Division of Dermatology, University of Kansas Medical Center, Kansas City, KS. arajpara@kumc.edu.
Zitieren
APA
Vetos, D., Wu, D. J., Downing, M. B., & Rajpara, A. (2021). Adalimumab for treatment of severe ulcerative sarcoidosis. Dermatology Online Journal, 27(6). https://doi.org/10.5070/d327654058
Vancouver
Vetos D, Wu DJ, Downing MB, Rajpara A. Adalimumab for treatment of severe ulcerative sarcoidosis. Dermatology Online Journal. 2021;27(6). doi:10.5070/d327654058
BibTeX
@article{Vetos2021,
author = {Vetos, Develyn and Wu, Dominic J and Downing, Malia B and Rajpara, Anand},
title = {Adalimumab for treatment of severe ulcerative sarcoidosis},
journal = {Dermatology Online Journal},
year = {2021},
volume = {27},
number = {6},
doi = {10.5070/d327654058}
}
EUVIMED